Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 3, 2003, Pages 568-575

  Khalil, Azza A ^a   Bentzen, Søren M ^a   Bernier, Jacques ^b   Saunders, Michele I ^a   Horiot, Jean Claude ^c   Van Den Bogaert, Walter ^d   Cummings, Bernard J ^e   Dische, Stanley ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b OSPEDALE SAN GIOVANNI   (Switzerland)

^c Tum Inst Ctr George Francois L   (France)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Altered fractionation; Clinical trials; Overall treatment time; Radiotherapy

Indexed keywords

HEALTH; PATIENT TREATMENT; TUMORS;

DOSE-FRACTIONATION;

RADIOTHERAPY;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; PATIENT COMPLIANCE; PERFORMANCE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0037361392     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03790-2     Document Type: Article

References (29)

1. Lindberg R.D., Jones K., Garner H.H., et al. Evaluation of unplanned interruptions in radiotherapy treatment schedules. Int J Radiat Oncol Biol Phys. 14:1988;811-815.
2. Harari P.M., Fowler F. Idealised versus realised overall treatment times. Int J Radiat Oncol Biol Phys. 29:1994;209-211.
3. Bentzen S.M., Overgaard M. Actual versus ideal treatment time in radiotherapy for head and neck cancer Catching up with the gaps . Int J Radiat Oncol Biol Phys. 31:1995;687-688.
4. Lai P.P., Pilepich M.V., Krall J.M., et al. The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma The Radiation Therapy Oncology Group 75-06 and 77-06 experience . [see comments] Int J Radiat Oncol Biol Phys. 21:1991;925-933.
5. Hendry J.H., Mackay R.I., Roberts S.A., et al. Outstanding issues in radiation dose-fractionation studies. Int J Radiat Biol. 73:1998;383-394.
6. Hendry J.H., Bentzen S.M., Dale R.G., et al. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol). 8:1996;297-307.
7. Wang C.C., Efrid J., Nakfoor B., et al. Local control of T3 carcinomas after accelerated fractionation A look at the gap . Int J Radiat Oncol Biol Phys. 35:1996;439-441.
8. Skladowski K., Law M.G., Maciejewski B., et al. Planned and unplanned gaps in radiotherapy The importance of gap position and gap duration . Radiother Oncol. 30:1994;109-120.
9. Robertson C., Robertson A.G., Hendry J.H., et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys. 40:1998;319-329.
10. Overgaard J., Sand Hansen H., Grau C., et al. The DAHANCA 6&7 trial A randomized multicenter study of 5 versus 6 fractions per week of conventional radiotherapy of squamous cell carcinoma (SCC) of the head and neck . Radiother Oncol. 56:(suppl. 1):2000;S4.
11. Horiot J.C., Le Fur R., N'Guyen T. Hyperfractionated versus conventional fractionation in oropharyngeal carcinoma Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy . Radiother Oncol. 25:1992;231-241.
12. van den Bogaert W., van der Schueren E., Horiot J.C. The EORTC randomized trial on three fractions per day and misonidazole (trial 22811) in advanced head and neck cancer Long term results and side effects . Radiother Oncol. 35:1995;91-99.
13. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers Results of the EORTC 22851 randomized trial . Radiother Oncol. 44:1997;111-121.
14. Cummings B.J. Benefits of accelerated hyperfractionation for head and neck cancer. Acta Oncol. 38:1999;131-136.
15. Dische S., Saunders M., Barrett A. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
16. Bentzen S.M., Johansen L.V., Overgaard J., et al. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 20:1991;1197-1206.
17. Allal A.S., De Pree C., Dulguerov P., et al. Avoidance of treatment interruption An unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinoma? Int J Radiat Oncol Biol Phys. 45:1999;41-45.
18. Fyles A., Keane T.J., Barton M., et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 25:1992;273-279.
19. Amdur R.J., Parsons J.T., Fitzgerald L.T., et al. The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy. Int J Radiat Oncol Biol Phys. 19:1990;1377-1382.
20. Pajak T.F., Laramore G.E., Marcial V.A., et al. Elapsed treatment days - a critical item for radiotherapy quality control review in head and neck trials RTOG report . Int J Radiat Oncol Biol Phys. 20:1991;13-20.
21. Perez C.A., Grigsby P.W., Castro-Vita H., et al. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 32:1995;1275-1288.
22. Eisenberg J.M. Sociologic influence on decision making by clinicians. Ann Intern Med. 90:1979;957-964.
23. Cox J.D., Pajak T.F., Asbell S., et al. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung Analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials . Int J Radiat Oncol Biol Phys. 27:1993;493-498.
24. De Neve W., Lybeert M.L., Goor C., et al. Radiotherapy for T2 and T3 carcinoma of the bladder The influence of overall treatment time . Radiother Oncol. 36:1995;183-188.
25. Bentzen S.M., Thames H.D. Clinical evidence for tumor clonogen regeneration Interpretations of the data . Radiother Oncol. 22:1991;161-166.
26. Richersen L., Cullen J.W. Compliance issues in management of patients with head and neck cancer. Kagan A.R., Miles J. Head and neck oncology clinical management. 1989;Pergamon Press, Oxford.
27. Newell S.A., Bowman J.A., Cockburn J.D. A critical review of interventions to increase compliance with medication taking, obtaining medication refills and appointment keeping in the treatment of cardiovascular disease. Prev Med. 29:1999;535-548.
28. Bentzen S.M. Time-dose relationships for human tumours Estimation from nonrandomised studies . Beck-Bornholdt H.P. Medical radiobiology, current topics in clinical radiobiology of tumours. 1993;11-26 Springer Verlag, Berlin.
29. Bentzen S.M. Radiobiological considerations in the design of clinical trials. Radiother Oncol. 32:1994;1-11.